KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Biomarin Pharmaceutical (BMRN) Receivables - Other (2016)

Biomarin Pharmaceutical (BMRN) has disclosed Receivables - Other for 5 consecutive years, with $8.4 million as the latest value for Q3 2016.

  • For the quarter ending Q3 2016, Receivables - Other changed N/A year-over-year to $8.4 million, compared with a TTM value of $8.4 million through Sep 2016, changed N/A, and an annual FY2013 reading of $116.5 million, changed N/A over the prior year.
  • Receivables - Other was $8.4 million for Q3 2016 at Biomarin Pharmaceutical, down from $116.5 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $116.5 million in Q4 2013 and bottomed at $6.8 million in Q1 2012.
  • Average Receivables - Other over 3 years is $30.1 million, with a median of $9.0 million recorded in 2012.
  • Peak annual rise in Receivables - Other hit 111.9% in 2012, while the deepest fall reached 23.81% in 2012.
  • Year by year, Receivables - Other stood at $9.0 million in 2012, then skyrocketed by 1191.86% to $116.5 million in 2013, then crashed by 92.79% to $8.4 million in 2016.
  • Business Quant data shows Receivables - Other for BMRN at $8.4 million in Q3 2016, $116.5 million in Q4 2013, and $9.0 million in Q3 2012.